

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.07636929 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.38188057 |
| 3 | cytidine deamination (GO:0009972) | 6.25651775 |
| 4 | cytidine metabolic process (GO:0046087) | 6.25651775 |
| 5 | cytidine catabolic process (GO:0006216) | 6.25651775 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.67642754 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.09484285 |
| 8 | sequestering of actin monomers (GO:0042989) | 4.52079490 |
| 9 | proteasome assembly (GO:0043248) | 4.47452090 |
| 10 | actin nucleation (GO:0045010) | 4.37523825 |
| 11 | iron-sulfur cluster assembly (GO:0016226) | 4.21063027 |
| 12 | metallo-sulfur cluster assembly (GO:0031163) | 4.21063027 |
| 13 | negative regulation by host of viral transcription (GO:0043922) | 4.19942695 |
| 14 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.03632623 |
| 15 | base-excision repair, AP site formation (GO:0006285) | 3.95388136 |
| 16 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.78049251 |
| 17 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.76956793 |
| 18 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.69786593 |
| 19 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.69786593 |
| 20 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.69786593 |
| 21 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.65076948 |
| 22 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.65076948 |
| 23 | protein neddylation (GO:0045116) | 3.58348231 |
| 24 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.52784467 |
| 25 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.52784467 |
| 26 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.52543257 |
| 27 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.50419925 |
| 28 | negative regulation of ligase activity (GO:0051352) | 3.47007181 |
| 29 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.47007181 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.36689545 |
| 31 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.30409010 |
| 32 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.30251230 |
| 33 | negative regulation of T cell apoptotic process (GO:0070233) | 3.24900123 |
| 34 | platelet dense granule organization (GO:0060155) | 3.24668744 |
| 35 | positive thymic T cell selection (GO:0045059) | 3.23423369 |
| 36 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.19844686 |
| 37 | GPI anchor biosynthetic process (GO:0006506) | 3.17613259 |
| 38 | positive regulation of mitochondrial fission (GO:0090141) | 3.17450758 |
| 39 | positive regulation of defense response to virus by host (GO:0002230) | 3.15207118 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.14521520 |
| 41 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.14270647 |
| 42 | rRNA modification (GO:0000154) | 3.10386055 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.09664837 |
| 44 | ATP synthesis coupled proton transport (GO:0015986) | 3.09205074 |
| 45 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.09205074 |
| 46 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.07591585 |
| 47 | GPI anchor metabolic process (GO:0006505) | 3.06208393 |
| 48 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.04524237 |
| 49 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.00979007 |
| 50 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.99723308 |
| 51 | positive T cell selection (GO:0043368) | 2.98539470 |
| 52 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.97929302 |
| 53 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.95269610 |
| 54 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.95269610 |
| 55 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.92826965 |
| 56 | eosinophil chemotaxis (GO:0048245) | 2.92817686 |
| 57 | ubiquinone biosynthetic process (GO:0006744) | 2.92016478 |
| 58 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.89873062 |
| 59 | protein deneddylation (GO:0000338) | 2.89631650 |
| 60 | regulation of cellular amine metabolic process (GO:0033238) | 2.89050929 |
| 61 | positive regulation of cell cycle arrest (GO:0071158) | 2.84919288 |
| 62 | mannosylation (GO:0097502) | 2.83256110 |
| 63 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.83065968 |
| 64 | positive regulation of tolerance induction (GO:0002645) | 2.82963563 |
| 65 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.80271605 |
| 66 | positive regulation of ligase activity (GO:0051351) | 2.79643409 |
| 67 | positive regulation of protein homodimerization activity (GO:0090073) | 2.79081762 |
| 68 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.78866243 |
| 69 | ubiquinone metabolic process (GO:0006743) | 2.77181980 |
| 70 | negative regulation of viral genome replication (GO:0045071) | 2.75228716 |
| 71 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.74546813 |
| 72 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.74505919 |
| 73 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.74158322 |
| 74 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.73803612 |
| 75 | protein complex biogenesis (GO:0070271) | 2.71670103 |
| 76 | pseudouridine synthesis (GO:0001522) | 2.68502840 |
| 77 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.65443324 |
| 78 | protein-cofactor linkage (GO:0018065) | 2.64703463 |
| 79 | T cell migration (GO:0072678) | 2.62907422 |
| 80 | eosinophil migration (GO:0072677) | 2.62729247 |
| 81 | cullin deneddylation (GO:0010388) | 2.60338684 |
| 82 | regulation of T cell tolerance induction (GO:0002664) | 2.59769310 |
| 83 | DNA double-strand break processing (GO:0000729) | 2.58510040 |
| 84 | regulation of interleukin-8 secretion (GO:2000482) | 2.58358786 |
| 85 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.58321345 |
| 86 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.58079843 |
| 87 | organelle disassembly (GO:1903008) | 2.57782544 |
| 88 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.57184402 |
| 89 | negative T cell selection (GO:0043383) | 2.56876468 |
| 90 | peptidyl-arginine N-methylation (GO:0035246) | 2.56422650 |
| 91 | peptidyl-arginine methylation (GO:0018216) | 2.56422650 |
| 92 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.56402921 |
| 93 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.55882849 |
| 94 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54057383 |
| 95 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.54035485 |
| 96 | deoxyribonucleotide catabolic process (GO:0009264) | 2.53813868 |
| 97 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.53199863 |
| 98 | histone arginine methylation (GO:0034969) | 2.53109204 |
| 99 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.52114407 |
| 100 | DNA demethylation (GO:0080111) | 2.51603800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.92097441 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.70298094 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.64298166 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.56213506 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.30143552 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.42959679 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.37213463 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.28051745 |
| 9 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.92381302 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.84914564 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.72324184 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56449255 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54058756 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.53015130 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.46275100 |
| 16 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.43956483 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.43168315 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.29297973 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.24295303 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.23814233 |
| 21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.10197033 |
| 22 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.92928341 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.89043507 |
| 24 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.83560013 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.82499281 |
| 26 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.81112678 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.78850656 |
| 28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.76892193 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73626798 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72838791 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.72336506 |
| 32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.71527384 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.71061571 |
| 34 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.69434463 |
| 35 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.66332813 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63232621 |
| 37 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.60533867 |
| 38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.59109001 |
| 39 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.54142870 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53979649 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51164525 |
| 42 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48698801 |
| 43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.48555610 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.47557973 |
| 45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46711384 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45520091 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45214662 |
| 48 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43430696 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.42621730 |
| 50 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.39760475 |
| 51 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38029209 |
| 52 | GATA3_26560356_Chip-Seq_TH2_Human | 1.36964552 |
| 53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.36562262 |
| 54 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.36363681 |
| 55 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.33578798 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33052095 |
| 57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33041603 |
| 58 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.29300734 |
| 59 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.26437932 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20920299 |
| 61 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20759750 |
| 62 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18978956 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17486185 |
| 64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16702282 |
| 65 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16400988 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14129826 |
| 67 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13975394 |
| 68 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.13927534 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.12855158 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12531668 |
| 71 | AR_20517297_ChIP-Seq_VCAP_Human | 1.12502558 |
| 72 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.10445953 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06314865 |
| 74 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05992112 |
| 75 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05873881 |
| 76 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05606282 |
| 77 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.04900561 |
| 78 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.99765279 |
| 79 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99275031 |
| 80 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97464849 |
| 81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.97067774 |
| 82 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96283161 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.94312980 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.94312980 |
| 85 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.92867448 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91657826 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91539228 |
| 88 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91294468 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 0.86501355 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85814816 |
| 91 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.85685928 |
| 92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85269167 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85044783 |
| 94 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84491302 |
| 95 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.83438872 |
| 96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.82439428 |
| 97 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.81450343 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 0.80063259 |
| 99 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.78940645 |
| 100 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.78922571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.77767709 |
| 2 | MP0009785_altered_susceptibility_to | 3.27014988 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 2.92950019 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.89082181 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.77201075 |
| 6 | MP0004147_increased_porphyrin_level | 2.66592657 |
| 7 | MP0000372_irregular_coat_pigmentation | 2.43300990 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.18751157 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.10488324 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.05688360 |
| 11 | MP0008058_abnormal_DNA_repair | 2.05119647 |
| 12 | MP0006082_CNS_inflammation | 2.04024083 |
| 13 | MP0001800_abnormal_humoral_immune | 2.02617097 |
| 14 | MP0003011_delayed_dark_adaptation | 2.01910549 |
| 15 | MP0003693_abnormal_embryo_hatching | 1.99667320 |
| 16 | MP0005253_abnormal_eye_physiology | 1.98954053 |
| 17 | MP0002723_abnormal_immune_serum | 1.98064488 |
| 18 | MP0001986_abnormal_taste_sensitivity | 1.96184020 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.94964004 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.93307915 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.91874813 |
| 22 | MP0001819_abnormal_immune_cell | 1.87283530 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 1.85239965 |
| 24 | MP0003786_premature_aging | 1.79719131 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77973263 |
| 26 | MP0002006_tumorigenesis | 1.72422065 |
| 27 | MP0002102_abnormal_ear_morphology | 1.70945681 |
| 28 | MP0008872_abnormal_physiological_respon | 1.70354631 |
| 29 | MP0005084_abnormal_gallbladder_morpholo | 1.69610167 |
| 30 | MP0005387_immune_system_phenotype | 1.67519756 |
| 31 | MP0001790_abnormal_immune_system | 1.67519756 |
| 32 | MP0005025_abnormal_response_to | 1.65608003 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.64320183 |
| 34 | MP0001529_abnormal_vocalization | 1.59868042 |
| 35 | MP0009764_decreased_sensitivity_to | 1.57900939 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.54270075 |
| 37 | MP0001764_abnormal_homeostasis | 1.53936931 |
| 38 | MP0002398_abnormal_bone_marrow | 1.45465768 |
| 39 | MP0010094_abnormal_chromosome_stability | 1.44770455 |
| 40 | MP0000716_abnormal_immune_system | 1.44323462 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.42533413 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.41701592 |
| 43 | MP0001984_abnormal_olfaction | 1.40360173 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.39831198 |
| 45 | MP0000685_abnormal_immune_system | 1.39055561 |
| 46 | MP0003866_abnormal_defecation | 1.33342779 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.33043468 |
| 48 | MP0008007_abnormal_cellular_replicative | 1.30943342 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.28840029 |
| 50 | MP0002722_abnormal_immune_system | 1.28463817 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.26587020 |
| 52 | MP0003724_increased_susceptibility_to | 1.26582014 |
| 53 | MP0003195_calcinosis | 1.21582612 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.21410825 |
| 55 | MP0001919_abnormal_reproductive_system | 1.21000019 |
| 56 | MP0001905_abnormal_dopamine_level | 1.20877538 |
| 57 | MP0002429_abnormal_blood_cell | 1.18846696 |
| 58 | MP0004957_abnormal_blastocyst_morpholog | 1.17633919 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 1.17494877 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.17479909 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.17430662 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.15589825 |
| 63 | MP0006054_spinal_hemorrhage | 1.12867041 |
| 64 | MP0003718_maternal_effect | 1.11465649 |
| 65 | MP0009763_increased_sensitivity_to | 1.09907175 |
| 66 | MP0002405_respiratory_system_inflammati | 1.09242572 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.09002719 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.07730553 |
| 69 | MP0005389_reproductive_system_phenotype | 1.02804883 |
| 70 | MP0008469_abnormal_protein_level | 1.01985109 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 0.98630330 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 0.98509927 |
| 73 | MP0004043_abnormal_pH_regulation | 0.97500255 |
| 74 | MP0001188_hyperpigmentation | 0.96245681 |
| 75 | MP0001968_abnormal_touch/_nociception | 0.94853227 |
| 76 | MP0001873_stomach_inflammation | 0.94421190 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.94049554 |
| 78 | MP0008932_abnormal_embryonic_tissue | 0.94029770 |
| 79 | MP0002736_abnormal_nociception_after | 0.93402053 |
| 80 | MP0003186_abnormal_redox_activity | 0.93314733 |
| 81 | MP0005646_abnormal_pituitary_gland | 0.91454000 |
| 82 | MP0002419_abnormal_innate_immunity | 0.91041216 |
| 83 | MP0005410_abnormal_fertilization | 0.88451932 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.87502943 |
| 85 | MP0008873_increased_physiological_sensi | 0.86861334 |
| 86 | MP0002933_joint_inflammation | 0.86680656 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 0.85129253 |
| 88 | MP0002234_abnormal_pharynx_morphology | 0.83587857 |
| 89 | MP0001542_abnormal_bone_strength | 0.83183039 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.81148220 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78969081 |
| 92 | MP0001119_abnormal_female_reproductive | 0.77518365 |
| 93 | MP0006276_abnormal_autonomic_nervous | 0.77496653 |
| 94 | MP0005464_abnormal_platelet_physiology | 0.77454360 |
| 95 | MP0006292_abnormal_olfactory_placode | 0.77344277 |
| 96 | MP0003448_altered_tumor_morphology | 0.74025318 |
| 97 | MP0003567_abnormal_fetal_cardiomyocyte | 0.71327182 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.71127121 |
| 99 | MP0003880_abnormal_central_pattern | 0.70209233 |
| 100 | MP0003252_abnormal_bile_duct | 0.66249610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgG deficiency (HP:0004315) | 4.45102296 |
| 2 | T lymphocytopenia (HP:0005403) | 4.38116019 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 4.30540048 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.26071900 |
| 5 | Increased IgM level (HP:0003496) | 4.12532850 |
| 6 | Abnormality of the prostate (HP:0008775) | 3.41482894 |
| 7 | Abnormality of eosinophils (HP:0001879) | 3.40401561 |
| 8 | Combined immunodeficiency (HP:0005387) | 3.39067366 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.38464449 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.37706838 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.23137146 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.23137146 |
| 13 | Abnormality of T cells (HP:0002843) | 3.19823505 |
| 14 | Increased intramyocellular lipid droplets (HP:0012240) | 3.17438368 |
| 15 | Abolished electroretinogram (ERG) (HP:0000550) | 3.15146927 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.14299282 |
| 17 | Thyroiditis (HP:0100646) | 3.14292728 |
| 18 | Hepatic necrosis (HP:0002605) | 3.14100927 |
| 19 | Increased CSF lactate (HP:0002490) | 3.09540166 |
| 20 | Increased hepatocellular lipid droplets (HP:0006565) | 3.06924641 |
| 21 | Congenital stationary night blindness (HP:0007642) | 3.06744414 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.90806964 |
| 23 | Acute necrotizing encephalopathy (HP:0006965) | 2.90097131 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 2.87817243 |
| 25 | Agammaglobulinemia (HP:0004432) | 2.82711877 |
| 26 | Increased serum lactate (HP:0002151) | 2.82095049 |
| 27 | Hypoproteinemia (HP:0003075) | 2.81923523 |
| 28 | Lipid accumulation in hepatocytes (HP:0006561) | 2.81789291 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78787645 |
| 30 | Eosinophilia (HP:0001880) | 2.75803845 |
| 31 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.67460785 |
| 32 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.67460785 |
| 33 | Abnormal protein glycosylation (HP:0012346) | 2.67460785 |
| 34 | Abnormal glycosylation (HP:0012345) | 2.67460785 |
| 35 | Type I transferrin isoform profile (HP:0003642) | 2.65460346 |
| 36 | Chronic diarrhea (HP:0002028) | 2.65300314 |
| 37 | Lactic acidosis (HP:0003128) | 2.60021244 |
| 38 | Encephalitis (HP:0002383) | 2.59043609 |
| 39 | Aplastic anemia (HP:0001915) | 2.54936184 |
| 40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.54354403 |
| 41 | Increased muscle lipid content (HP:0009058) | 2.53663229 |
| 42 | Renal cortical cysts (HP:0000803) | 2.53454839 |
| 43 | Renal Fanconi syndrome (HP:0001994) | 2.52313707 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.50710369 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.50710369 |
| 46 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.48257285 |
| 47 | Abnormality of alanine metabolism (HP:0010916) | 2.48257285 |
| 48 | Hyperalaninemia (HP:0003348) | 2.48257285 |
| 49 | Attenuation of retinal blood vessels (HP:0007843) | 2.43381709 |
| 50 | Acute encephalopathy (HP:0006846) | 2.43335985 |
| 51 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.39244964 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.38557652 |
| 53 | Stomatitis (HP:0010280) | 2.32125324 |
| 54 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.31511993 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.30919932 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30919932 |
| 57 | Cerebral edema (HP:0002181) | 2.29318343 |
| 58 | Progressive macrocephaly (HP:0004481) | 2.29102720 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.28307749 |
| 60 | Pancreatic cysts (HP:0001737) | 2.28286502 |
| 61 | Prostate neoplasm (HP:0100787) | 2.25356279 |
| 62 | Methylmalonic acidemia (HP:0002912) | 2.23903977 |
| 63 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.21219143 |
| 64 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.20986723 |
| 65 | Granulocytopenia (HP:0001913) | 2.18914659 |
| 66 | Abnormality of B cell number (HP:0010975) | 2.17579443 |
| 67 | Optic disc pallor (HP:0000543) | 2.13055678 |
| 68 | Methylmalonic aciduria (HP:0012120) | 2.12813262 |
| 69 | Decreased central vision (HP:0007663) | 2.12654195 |
| 70 | IgM deficiency (HP:0002850) | 2.12217531 |
| 71 | Pancytopenia (HP:0001876) | 2.12162655 |
| 72 | Emotional lability (HP:0000712) | 2.11761562 |
| 73 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.04690312 |
| 74 | Recurrent bronchitis (HP:0002837) | 2.01819344 |
| 75 | Medial flaring of the eyebrow (HP:0010747) | 2.01115845 |
| 76 | Microvesicular hepatic steatosis (HP:0001414) | 2.01032076 |
| 77 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.00659336 |
| 78 | Leukocytosis (HP:0001974) | 2.00656374 |
| 79 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.99087311 |
| 80 | Colon cancer (HP:0003003) | 1.97307374 |
| 81 | Parakeratosis (HP:0001036) | 1.96514999 |
| 82 | CNS demyelination (HP:0007305) | 1.95548833 |
| 83 | Type 2 muscle fiber atrophy (HP:0003554) | 1.93417076 |
| 84 | Hypoplasia of the thymus (HP:0000778) | 1.86373564 |
| 85 | Abnormality of male internal genitalia (HP:0000022) | 1.86173890 |
| 86 | Exercise intolerance (HP:0003546) | 1.84584233 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 1.83657282 |
| 88 | Hyperglycinemia (HP:0002154) | 1.83186951 |
| 89 | Generalized aminoaciduria (HP:0002909) | 1.82226591 |
| 90 | Respiratory failure (HP:0002878) | 1.80397809 |
| 91 | Abnormality of midbrain morphology (HP:0002418) | 1.79399291 |
| 92 | Molar tooth sign on MRI (HP:0002419) | 1.79399291 |
| 93 | Muscle fiber atrophy (HP:0100295) | 1.78708024 |
| 94 | Lymphoma (HP:0002665) | 1.78264468 |
| 95 | Constricted visual fields (HP:0001133) | 1.75956102 |
| 96 | Cerebral hypomyelination (HP:0006808) | 1.74962698 |
| 97 | Lethargy (HP:0001254) | 1.73730710 |
| 98 | Abnormality of the anterior horn cell (HP:0006802) | 1.72062851 |
| 99 | Degeneration of anterior horn cells (HP:0002398) | 1.72062851 |
| 100 | Abnormal biliary tract physiology (HP:0012439) | 1.71443990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 6.23747903 |
| 2 | KDR | 3.81093186 |
| 3 | ZAK | 3.70523598 |
| 4 | VRK2 | 3.30932206 |
| 5 | TXK | 2.73078185 |
| 6 | TLK1 | 2.72940124 |
| 7 | BCKDK | 2.60963008 |
| 8 | SRPK1 | 2.46468612 |
| 9 | LIMK1 | 2.33785744 |
| 10 | MAP4K2 | 2.28979128 |
| 11 | STK16 | 2.13986652 |
| 12 | TESK1 | 2.11344220 |
| 13 | GRK1 | 2.05908538 |
| 14 | EIF2AK3 | 2.01042816 |
| 15 | VRK1 | 2.00797297 |
| 16 | BCR | 1.95852098 |
| 17 | ADRBK2 | 1.88862157 |
| 18 | TIE1 | 1.82806951 |
| 19 | MAP4K1 | 1.69538455 |
| 20 | NUAK1 | 1.58017614 |
| 21 | TRIM28 | 1.55867865 |
| 22 | MAPKAPK3 | 1.54587902 |
| 23 | TAOK3 | 1.50395876 |
| 24 | CSNK1G3 | 1.47238786 |
| 25 | RPS6KA4 | 1.43073761 |
| 26 | CSNK1A1L | 1.33925710 |
| 27 | MAP2K7 | 1.31326326 |
| 28 | DAPK1 | 1.30698104 |
| 29 | BUB1 | 1.30084559 |
| 30 | ITK | 1.23497931 |
| 31 | MST4 | 1.18164844 |
| 32 | CSF1R | 1.17997286 |
| 33 | CSNK1G1 | 1.04709274 |
| 34 | FES | 1.04070770 |
| 35 | CSNK1G2 | 1.02766076 |
| 36 | MAP3K12 | 0.97327583 |
| 37 | TAF1 | 0.94635828 |
| 38 | CDK19 | 0.94126430 |
| 39 | TEC | 0.92840114 |
| 40 | GRK6 | 0.92709452 |
| 41 | BMPR1B | 0.92467372 |
| 42 | PRKCQ | 0.91717924 |
| 43 | ERBB3 | 0.91293078 |
| 44 | PLK4 | 0.89452097 |
| 45 | SCYL2 | 0.88044495 |
| 46 | SYK | 0.87114715 |
| 47 | MAP3K4 | 0.79378220 |
| 48 | KIT | 0.78418407 |
| 49 | RPS6KA5 | 0.75631122 |
| 50 | IKBKB | 0.74221871 |
| 51 | MUSK | 0.70457051 |
| 52 | LCK | 0.69276685 |
| 53 | PLK3 | 0.68182076 |
| 54 | DYRK2 | 0.65103855 |
| 55 | PINK1 | 0.65003789 |
| 56 | PLK2 | 0.63139085 |
| 57 | NEK1 | 0.62730806 |
| 58 | EIF2AK1 | 0.62643794 |
| 59 | CDC7 | 0.61640740 |
| 60 | ATR | 0.61337018 |
| 61 | WNK3 | 0.60291609 |
| 62 | TNK2 | 0.59430592 |
| 63 | CCNB1 | 0.59150058 |
| 64 | INSRR | 0.58959255 |
| 65 | AURKA | 0.55643523 |
| 66 | LYN | 0.54403744 |
| 67 | MAPK13 | 0.54085692 |
| 68 | TBK1 | 0.52741791 |
| 69 | MATK | 0.52370345 |
| 70 | PIM2 | 0.52008054 |
| 71 | CAMKK2 | 0.51809251 |
| 72 | PASK | 0.50904503 |
| 73 | BTK | 0.49752777 |
| 74 | MAPKAPK5 | 0.47386991 |
| 75 | IKBKE | 0.45984306 |
| 76 | LMTK2 | 0.44943419 |
| 77 | AURKB | 0.44117477 |
| 78 | MAP3K14 | 0.42556911 |
| 79 | GRK7 | 0.42428799 |
| 80 | CSNK2A1 | 0.42426055 |
| 81 | EIF2AK2 | 0.42058637 |
| 82 | PDK2 | 0.41379470 |
| 83 | TSSK6 | 0.40947153 |
| 84 | MKNK1 | 0.40847949 |
| 85 | WNK4 | 0.39822342 |
| 86 | FRK | 0.38465584 |
| 87 | GRK5 | 0.37757686 |
| 88 | PIK3CA | 0.35769424 |
| 89 | MAPK11 | 0.33438265 |
| 90 | IGF1R | 0.33326283 |
| 91 | PLK1 | 0.32948784 |
| 92 | CDK7 | 0.31603248 |
| 93 | CSNK1A1 | 0.31446196 |
| 94 | CSK | 0.31079023 |
| 95 | NME1 | 0.30258477 |
| 96 | DAPK2 | 0.24332787 |
| 97 | PRKCE | 0.24276978 |
| 98 | MAP3K11 | 0.24233284 |
| 99 | PRKCA | 0.24225671 |
| 100 | MYLK | 0.22681128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.10804473 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.03517276 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.56450659 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.56273956 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.51626099 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.39830894 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.29774582 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.20182339 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.17904534 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.16266680 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.14139751 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.09020299 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81183612 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 1.76815361 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.64489214 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63171458 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.61116821 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.58267477 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.57416321 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.53461399 |
| 21 | Mismatch repair_Homo sapiens_hsa03430 | 1.53231110 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48449364 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.44022608 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.43212244 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.32094904 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26216113 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.25079189 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.23438871 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.19983292 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17404146 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.16583154 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.16333099 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.14635651 |
| 34 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14532935 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14240544 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.14222147 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.12426708 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11062621 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10555134 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.10350217 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.08813008 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.07888532 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.06586978 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05833752 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 1.05643305 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00975078 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99385644 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97829082 |
| 49 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97238718 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94874771 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93791855 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92775494 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92736397 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91914404 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.90122416 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 0.89276438 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88218250 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87588632 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85733620 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84707446 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83951052 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83634358 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72664029 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72389117 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72160899 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71458151 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69863656 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68939584 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68549173 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66844224 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65709253 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64865035 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64057077 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62929498 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59745148 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59567253 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.58994938 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57330536 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56758234 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55961925 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49176822 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49032547 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48914588 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48518992 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47394122 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47260874 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47209776 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46816118 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46450426 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.46442504 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46417130 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45002372 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39404023 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38324883 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36833643 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36684387 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.36109011 |
| 98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32926415 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30416340 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30181117 |

